GURUFOCUS.COM » STOCK LIST » USA » NYSE » Nuvation Bio Inc (NYSE:NUVB.WS) » Definitions » Cash Ratio
Switch to:

Nuvation Bio Cash Ratio

: 33.08 (As of Jun. 2022)
View and export this data going back to 2021. Start your Free Trial

The Cash Ratio measures a company’s ability to meet its short-term obligations with cash and near-cash resources. It is calculated as a company's Cash, Cash Equivalents, Marketable Securities divides by its Total Current Liabilities. Nuvation Bio's Cash Ratio for the quarter that ended in Jun. 2022 was 33.08.

Nuvation Bio has a Cash Ratio of 33.08. It generally indicates that the company is able to cover all short-term debt and still have cash remaining.

The historical rank and industry rank for Nuvation Bio's Cash Ratio or its related term are showing as below:

NUVB.WS' s Cash Ratio Range Over the Past 10 Years
Min: 32.93   Med: 45.22   Max: 82.58
Current: 33.08

During the past 2 years, Nuvation Bio's highest Cash Ratio was 82.58. The lowest was 32.93. And the median was 45.22.

NUVB.WS's Cash Ratio is ranked better than
95.86% of 1545 companies
in the Biotechnology industry
Industry Median: 4.51 vs NUVB.WS: 33.08

Nuvation Bio Cash Ratio Historical Data

The historical data trend for Nuvation Bio's Cash Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nuvation Bio Annual Data
Trend Dec20 Dec21
Cash Ratio
32.93 45.22

Nuvation Bio Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
Cash Ratio Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.94 59.50 45.22 34.41 33.08

Competitive Comparison

For the Biotechnology subindustry, Nuvation Bio's Cash Ratio, along with its competitors' market caps and Cash Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Nuvation Bio Cash Ratio Distribution

For the Biotechnology industry and Healthcare sector, Nuvation Bio's Cash Ratio distribution charts can be found below:

* The bar in red indicates where Nuvation Bio's Cash Ratio falls into.



Nuvation Bio Cash Ratio Calculation

The Cash Ratio measures a company's ability to meet its short-term obligations with its cash and near-cash resources.

Nuvation Bio's Cash Ratio for the fiscal year that ended in Dec. 2021 is calculated as:

Cash Ratio (A: Dec. 2021 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=765.392/16.925
=45.22

Nuvation Bio's Cash Ratio for the quarter that ended in Jun. 2022 is calculated as:

Cash Ratio (Q: Jun. 2022 )=Cash, Cash Equivalents, Marketable Securities/Total Current Liabilities
=703.797/21.274
=33.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nuvation Bio  (NYSE:NUVB.WS) Cash Ratio Explanation

The cash ratio is more conservative than other liquidity ratios, such as Quick Ratio and Current Ratio, because it only considers a company's most liquid resources. The numerator of cash ratio only considers Cash, Cash Equivalents and marketable securities. Other current assets, such as accounts receivable and inventories, are not included. The rationale is that these assets may require time to be transformed into cash, and the amount of money received is also uncertain.

The cash ratio shows a company’s ability to pay all current liabilities immediately without selling or liquidating other assets. Generally speaking, a higher cash ratio suggests the company has a stronger ability to cover its short-term debt. However, a high cash ratio could also indicate inefficient management: the company is inefficient in making full utilization of cash to invest protential profitable project. It may also suggest that the company is not confident about future profitability.

In general, the higher the cash ratio, the better the company's liquidity position.


Nuvation Bio Cash Ratio Related Terms

Thank you for viewing the detailed overview of Nuvation Bio's Cash Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Nuvation Bio Business Description

Nuvation Bio logo
Traded in Other Exchanges
Address
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. The company's proprietary portfolio includes around six novel and mechanistically distinct oncology therapeutic product candidates, each targeting some of the most difficult-to-treat types of cancer.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)